An Open-lable Trial of Subcutaneous Semaglutide in Systemic Scleroderma

Conditions: Scleroderma, Systemic; Fibrosis; Semaglutide Interventions: Drug: Semaglutide Pen Injector Sponsors: Second Xiangya Hospital of Central South University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials